Literature DB >> 25588281

Migraine is underdiagnosed and undertreated.

Sarah Miller1, Manjit S Matharu.   

Abstract

Migraine is a common neurovascular disorder characterised by attacks of head pain that are typically unilateral and often described as severe and throbbing in association with nausea and sensitivity to sensory input, i.e. light, sound and head movement. The headaches typically last 4-72 hours, up to 31% of migraineurs have aura on some occasions. Migraine is commonly episodic. With an increasing intake of painkillers, patients often complain of an escalation of migraine attacks or a transformation to a chronic daily background pain with exacerbations. Acute painkiller use, both prescription and OTC, should be enquired about in all cases and medication overuse headache suspected and managed if patients are taking any acute painkiller excessively. Migraineurs should be encouraged to have regular habits. Regular sleep, exercise, meals, work habits and relaxation will be rewarded by a reduction in headache frequency. NICE guidelines recommend adopting the stepped-down approach to management. They suggest a combination of a triptan, NSAID or paracetamol, and an anti-emetic taken as early as possible during the headache. The decision to commence a preventative agent should depend on a combination of attack frequency, duration and severity, as well as response to abortive therapy and patient preference.

Entities:  

Mesh:

Year:  2014        PMID: 25588281

Source DB:  PubMed          Journal:  Practitioner        ISSN: 0032-6518


  9 in total

Review 1.  Prevention, education and counselling: the worldwide role of the community pharmacist as an epidemiological sentinel of headaches.

Authors:  Francesca Baratta; Gianni Allais; Sara Rolando; Gian Camillo Manzoni; Gennaro Bussone; Chiara Benedetto; Cecilia Scarinzi; Roberto Gnavi; Teresa Spadea; Giuseppe Costa; Marco Parente; Massimo Mana; Mario Giaccone; Andrea Mandelli; Paola Brusa
Journal:  Neurol Sci       Date:  2019-05       Impact factor: 3.307

2.  Analysis of Genetic Variants in SCN1A, SCN2A, KCNK18, TRPA1 and STX1A as a Possible Marker of Migraine.

Authors:  Marta Kowalska; Michał Prendecki; Magdalena Kapelusiak-Pielok; Teresa Grzelak; Urszula Łagan-Jędrzejczyk; Małgorzata Wiszniewska; Wojciech Kozubski; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2020-04       Impact factor: 2.236

3.  Plasma Levels of Cyclooxygenase-2 (COX-2) and Visfatin During Different Stages and Different Subtypes of Migraine Headaches.

Authors:  Chao Li; Qiushi Zhu; Qiu He; Junwei Wang; Fengzhi Wang; Hemin Zhang
Journal:  Med Sci Monit       Date:  2017-01-03

4.  Self-medication for migraine: A nationwide cross-sectional study in Italy.

Authors:  Paola Brusa; Gianni Allais; Cecilia Scarinzi; Francesca Baratta; Marco Parente; Sara Rolando; Roberto Gnavi; Teresa Spadea; Giuseppe Costa; Chiara Benedetto; Massimo Mana; Mario Giaccone; Andrea Mandelli; Gian Camillo Manzoni; Gennaro Bussone
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

Review 5.  Identifying and managing refractory migraine: barriers and opportunities?

Authors:  Linda D'Antona; Manjit Matharu
Journal:  J Headache Pain       Date:  2019-08-23       Impact factor: 7.277

6.  Narrative Medicine to integrate patients', caregivers' and clinicians' migraine experiences: the DRONE multicentre project.

Authors:  Maria Clara Tonini; Alessandra Fiorencis; Rosario Iannacchero; Mauro Zampolini; Antonietta Cappuccio; Raffaella Raddino; Elisabetta Grillo; Maria Albanese; Gianni Allais; Marco André Bassano; Filippo Brighina; Terenzio Carboni; Fabio Frediani; Licia Grazzi; Carmela Mastrandrea; Franca Moschiano; Maria Gabriella Poeta; Angelo Ranieri; Renato Turrini; Maria Giulia Marini
Journal:  Neurol Sci       Date:  2021-04-15       Impact factor: 3.307

7.  Migraine in physicians and final year medical students: A cross-sectional insight into prevalence, self-awareness, and knowledge from Pakistan.

Authors:  Hassan Choudry; Fateen Ata; Muhammad Naveed Naveed Alam; Ruqaiya Ruqaiya; Mahammed Khan Suheb; Muhammad Qaiser Ikram; Muhammad Muzammil Chouhdry; Muaz Muaz
Journal:  World J Methodol       Date:  2022-09-20

8.  Diagnosis and treatment for chronic migraine.

Authors:  Maureen Moriarty; Theresa Mallick-Searle
Journal:  Nurse Pract       Date:  2016-06-19

Review 9.  Clinical Evidence of Cannabinoids in Migraine: A Narrative Review.

Authors:  Flavia Lo Castro; Carlo Baraldi; Lanfranco Pellesi; Simona Guerzoni
Journal:  J Clin Med       Date:  2022-03-08       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.